Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  The percentage set forth on row (11) above and the number of shares of common stock, par value $0.0001 per share, of the issuer (the "Common Stock") set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount (as defined in this footnote), the shares of Common Stock to be issued upon (a) conversions of two senior secured convertible promissory notes (the "Convertible Notes"), (with the first issued on August 31, 2026 and the second issued on September 4, 2026), held directly by the reporting person and (b) a warrant to purchase shares of Common Stock issued on August 31, 2026 (the "Warrant"). The Convertible Notes and the Warrant are all subject to a maximum 9.99% beneficial ownership limitation contained therein (the "Blocker Amount"). In Row (11) the percentage is based on (i) 5,732,739 shares of Common Stock outstanding as of September 22, 2026, as reported by the issuer in Amendment 3 to Form S-1, which amendment was filed with the U.S. Securities and Exchange Commission on September 22, 2026 (the "S-1") and (ii) shares of Common Stock issuable upon partial conversions of the Convertible Notes and partial exercises of the Warrant, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person:  The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon conversions of the Convertible Notes and exercises of the Warrant. The Convertible Notes and Warrant are all limited by the Blocker Amount. In Row (11) the percentage is based on (i) 5,732,739 shares of Common Stock outstanding as of September 22, 2026, as reported by the issuer in its S-1 and (ii) shares of Common Stock issuable upon partial conversions of the Convertible Notes and partial exercises of the Warrant, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person:  The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon conversions of the Convertible Notes and exercises of the Warrant. The Convertible Notes and Warrant are all limited by the Blocker Amount. In Row (11) the percentage is based on (i) 5,732,739 shares of Common Stock outstanding as of September 22, 2026, as reported by the issuer in its S-1 and (ii) shares of Common Stock issuable upon partial conversions of the Convertible Notes and partial exercises of the Warrant, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person:  The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon conversions of the Convertible Notes and exercises of the Warrant. The Convertible Notes and Warrant are all limited by the Blocker Amount. In Row (11) the percentage is based on (i) 5,732,739 shares of Common Stock outstanding as of September 22, 2026, as reported by the issuer in its S-1 and (ii) shares of Common Stock issuable upon partial conversions of the Convertible Notes and partial exercises of the Warrant, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person:  The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon conversions of the Convertible Notes and exercises of the Warrant. The Convertible Notes and Warrant are all limited by the Blocker Amount. In Row (11) the percentage is based on (i) 5,732,739 shares of Common Stock outstanding as of September 22, 2026, as reported by the issuer in its S-1 and (ii) shares of Common Stock issuable upon partial conversions of the Convertible Notes and partial exercises of the Warrant, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person:  The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon conversions of the Convertible Notes and exercises of the Warrant. The Convertible Notes and Warrant are all limited by the Blocker Amount. In Row (11) the percentage is based on (i) 5,732,739 shares of Common Stock outstanding as of September 22, 2026, as reported by the issuer in its S-1 and (ii) shares of Common Stock issuable upon partial conversions of the Convertible Notes and partial exercises of the Warrant, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person:  The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon conversions of the Convertible Notes and exercises of the Warrant. The Convertible Notes and Warrant are all limited by the Blocker Amount. In Row (11) the percentage is based on (i) 5,732,739 shares of Common Stock outstanding as of September 22, 2026, as reported by the issuer in its S-1 and (ii) shares of Common Stock issuable upon partial conversions of the Convertible Notes and partial exercises of the Warrant, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person:  The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon conversions of the Convertible Notes and exercises of the Warrant. The Convertible Notes and Warrant are all limited by the Blocker Amount. In Row (11) the percentage is based on (i) 5,732,739 shares of Common Stock outstanding as of September 22, 2026, as reported by the issuer in its S-1 and (ii) shares of Common Stock issuable upon partial conversions of the Convertible Notes and partial exercises of the Warrant, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person:  The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon conversions of the Convertible Notes and exercises of the Warrant. The Convertible Notes and Warrant are all limited by the Blocker Amount. In Row (11) the percentage is based on (i) 5,732,739 shares of Common Stock outstanding as of September 22, 2026, as reported by the issuer in its S-1 and (ii) shares of Common Stock issuable upon partial conversions of the Convertible Notes and partial exercises of the Warrant, in each case subject to the Blocker Amount.


SCHEDULE 13G



 
Ascent Partners Fund LLC
 
Signature:/s/ Ascent Partners Fund LLC
Name/Title:Mikhail Gurevich, signatory for Managing Member of Managing Member
Date:10/27/2026
 
Ascent Partners LLC
 
Signature:/s/ Ascent Partners LLC
Name/Title:Mikhail Gurevich, signatory for Managing Member
Date:10/27/2026
 
Dominion Capital LLC
 
Signature:/s/ Dominion Capital LLC
Name/Title:Mikhail Gurevich, Chief Investment Officer of Eagle Claw Corp., Manager of Dominion Capital GP LLC, Manager of Dominion Capital LLC
Date:10/27/2026
 
Dominion Capital GP LLC
 
Signature:/s/ Dominion Capital GP LLC
Name/Title:Mikhail Gurevich, Chief Investment Officer of Eagle Claw Corp., Manager of Dominion Capital GP LLC
Date:10/27/2026
 
Eagle Claw Corp.
 
Signature:/s/ Eagle Claw Corp.
Name/Title:Gennadiy Gurevich, President
Date:10/27/2026
 
Masada Group Holdings LLC
 
Signature:/s/ Masada Group Holdings LLC
Name/Title:Alon Brenner, Managing Member
Date:10/27/2026
 
Mikhail Gurevich
 
Signature:/s/ Mikhail Gurevich
Name/Title:Mikhail Gurevich
Date:10/27/2026
 
Gennadiy Gurevich
 
Signature:/s/ Gennadiy Gurevich
Name/Title:Gennadiy Gurevich
Date:10/27/2026
 
Alon Brenner
 
Signature:/s/ Alon Brenner
Name/Title:Alon Brenner
Date:10/27/2026

Comments accompanying signature:  LIST OF EXHIBITS Exhibit No. 1 - Joint Filing Agreement, dated September 10, 2026 (incorporated by reference to Exhibit 1 to the Schedule 13G filed by the Reporting Persons with the SEC on September 10, 2026)